University of Cambridge

Our Funds: University Discovery Fund

Philanthropic support is vital for the very early high risk stages of new company formation.

The University Discovery Fund was created in 2008 by the University as a donated fund, celebrating their 800 year anniversary, to invest in science with clear commercial potential. The original raise was £1.8 million which has since returned £8.6 million (£6.3 million of profit) to invest in the next generation of innovation.

Mostly recently it has supported our Social Ventures programme, and the START programme for Founders at the University of Cambridge where the fund invested £20,000 into each of the cohort companies. This fund holds investments in more than 30 companies including Cambridge GAN Devices, Colorifix and Echion.

To learn more about the success of the University Discovery Fund, check out the 2010-2025 report.

Aetosense Deep Tech

Aetosense

AetoSense develops advanced air quality monitoring systems that enhance indoor air quality and optimise energy consumption by detecting ultrafine particles.

Point of Contact: Christine Martin Academic founder: Molly Haugen

Visit the website

Aqdot Deep Tech

Aqdot

Aqdot is a supramolecular chemistry company with a focus and expertise in developing, licensing and selling novel proprietary products.

Point of Contact: Christine Martin Academic founders: Oren Scherman, Chris Abell, Roger Coulston, Jing Zhang

Visit the website

Aspuna Group Social Ventures

Aspuna Group

Aspuna Group is a social impact commodities asset management business with a proven model for making trading fair.

Point of Contact: Amanda Wooding Academic founders: Maria-Yassin Yah, Luis Prazeres

Visit the website

Bit Bio Life Sciences

Bit Bio

Bit Bio is a synthetic biology company providing human cells for research, drug discovery and cell therapy.

Point of Contact: Amanda Wooding Academic founders: Mark Kotter, Benhard Klemen

Visit the website

BravelyCultured Sustainability

BravelyCultured

BravelyCultured is developing sustainable, skin-friendly biodegradable chemicals, with an initial focus on biosurfactants for personal and home care products.

Point of Contact: Chris Gibbs Academic founders: Natalija Stepurko, James Dunce

Visit the website

Cambridge GaN Devices Sustainability

Cambridge GaN Devices

Cambridge GaN Devices (CGD) is a fabless semiconductor company that develops a range of energy-efficient GaN-based power devices to make greener electronics possible.

Point of Contact: Chris Gibbs Academic founders: Giorgia Longobardi, Florin Udrea

Visit the website

Cambridge Vision Technology Life Sciences

Cambridge Vision Technology

Cambridge Vision Technology (CVT) is a medical device company specialising in diagnostic tests for early detection of eye and neurodegenerative diseases.

Point of Contact: Amanda Wooding Academic founders: Andrew Kadis, James Wood

Visit the website

CellCentric Life Sciences

CellCentric

CellCentric is a clinical stage biotech company; developing a novel anti-cancer drug, currently in clinical trials for prostate and haematological cancers.

Point of Contact: Amanda Wooding Academic founders: Will West, Azim Surani, Jessica Salter

Visit the website

Colorifix Sustainability

Colorifix

Colorifix is developing a revolutionary dyeing process to help the textile industry dramatically reduce its environmental impact.

Point of Contact: Chris Gibbs Academic founders: James Ajioka, David Nugent, Orr Yarkoni

Visit the website

Cosysense Social Ventures

Cosysense

Cosysense enhances energy efficiency in commercial buildings using advanced sensors and AI to optimise HVAC systems. Their solution reduces energy consumption and costs, with clients paying only a fraction of the savings achieved.

Point of Contact: Amanda Wooding Academic founders: Matias Acosta, Sebastian Horstmann

Visit the website

DefiniGEN Life Sciences

DefiniGEN

DefiniGEN is a company that provides optimised human cell products for scientific research, specialising in creating predictive cell-based models of liver disease to accelerate drug development.

Point of Contact: Amanda Wooding Academic founders: Roger Pedersen, Ludovic Vallier

Visit the website

Healthera Life Sciences

Healthera

Healthera is a health tech company providing a platform for ordering NHS prescriptions and accessing pharmacy services. They partner with over 1,600 pharmacies to offer medication management, delivery, and health services through their app.

Point of Contact: Amanda Wooding Academic founders: Tiannan Hao, Jin Dai, Victor Wong, Sichen Liu

Visit the website

Immaterial Deep Tech

Immaterial

Immaterial Ltd have the in-depth expertise and know-how to design a system solution with optimised monolithic metal-organic framework materials around a process tailored to your operating conditions.

Point of Contact: Christine Martin Academic founders: Andrew Marsden, Mohammed Khan

Visit the website

Kalamna Global Social Ventures

Kalamna Global

Kalamna Global is an award-winning social enterprise that empowers families to connect with and celebrate their culture and heritage through the Arabic language.

Point of Contact: Amanda Wooding Academic founders: Yosra Koura, Saussan Khalil

Visit the website

Majico Social Ventures

Majico

Majico designs and develops innovative water kiosk solutions, combining human-centered design, novel purification technologies, and automated water management to address drinking water issues in East Africa.

Point of Contact: Amanda Wooding Academic founders: Michael Coto, Peter Knight

Visit the website

Molyon Sustainability

Molyon

Molyon develops high-energy density lithium-sulfur batteries for weight-critical applications, offering twice the energy density of current lithium-ion batteries.

Point of Contact: Chris Gibbs Academic founders: Ismail Sami, Manish Chhowalla

Visit the website

Nanomation Deep Tech

Nanomation

Nanomation is a semiconductor software company that enables the industry to unlock the transformative power of nanomaterials.

Point of Contact: Christine Martin Academic founders: Charlotte Esler, Jack Alexander-Webber, Teja Potočnik

Visit the website

Obliquity Group Social Ventures

Obliquity Group

Obliquity Group have developed breakthrough employee-focused data analytics that enables more inclusive, quantified and embedded sustainability strategies.

Point of Contact: Amanda Wooding Academic founders: John Isherwood, Simon Kelly

Visit the website

Orbit Life Sciences

Orbit

Orbit uses non-invasive neurotech to make mental health as transparent and actionable as physical health.

Point of Contact: Amanda Wooding Academic founder: Akshat Sharma

Visit the website

PneumaCare Life Sciences

PneumaCare

PneumaCare Ltd is a Cambridge based company, developing the non-contact, non-invasive technology – Structured Light Plethysmography (SLP) which helps to assess lung function.

Point of Contact: Amanda Wooding Academic founders: Gareth Roberts, Richard Iles, Joan Lasenby

Visit the website

Polypharmakos Life Sciences

Polypharmakos

Polypharmakos is a joint venture between the University of Cambridge and the Royal Botanic Gardens, leveraging AI and deep ethnobotanical knowledge to discover and develop novel anti-inflammaging nutraceuticals and drugs from natural extracts.

Point of Contact: Amanda Wooding Academic founders: Clare Bryant, Duncan Maskell, Mark Holmes

Visit the website

Protonera Sustainability

Protonera

Protonera specialises in converting waste plastics into hydrogen, providing sustainable waste management solutions to reduce reliance on fossil fuels.

Point of Contact: Chris Gibbs Academic founders: Chengzhi Guo, Subhajit Bhattacharjee, Erwin Reisner

Visit the website

PsyOmics Life Sciences

PsyOmics

Psyomics is a company that enhances mental health care with digital solutions. Their main product, Censeo, helps clinicians by collecting detailed patient-reported mental health information, streamlining assessments, and improving patient experiences.

Point of Contact: Amanda Wooding Academic founders: Sabine Bahn, Kevin McDonnell, Melinda Rees

Visit the website

Sphere Bio Life Sciences

Sphere Bio

Sphere Bio is a life sciences company specialising in single cell analysis and isolation. They use picodroplet microfluidic technology to provide high-throughput platforms and consumables for biopharmaceutical discovery, cell therapy engineering, and synthetic biology.

Point of Contact: Amanda Wooding Academic founders: Chris Abell, Wilhelm Huck

Visit the website

Vector Bioscience Life Sciences

Vector Bioscience

Vector Bioscience Cambridge specialises in nanoparticle-based drug delivery systems for cancer treatment. Their technology uses machine learning to enhance precision and minimise side effects.

Point of Contact: Amanda Wooding Academic founders: David Fairen-Jimenez, Jogchum Brinksma

Visit the website

Voltquant Sustainability

Voltquant

Voltquant provides advanced AI and GIS software solutions to optimise infrastructure deployment and enhance efficiency in the energy sector.

Point of Contact: Chris Gibbs Academic founders: Nikita Dabizha, George Kolokotronis, Gareth Dauley

Visit the website

WaterScope Social Ventures

WaterScope

WaterScope's mission is to enable inclusive access to smart, easy-to-use, and reliable testing for bacterial presence in drinking water.

Point of Contact: Amanda Wooding Academic founder: Richard Bowman

Visit the website

Where You At Social Ventures

Where You At

WYA (Where You At) uses Bluetooth technology to help users locate friends in crowded venues by providing precise positioning and real-time updates, even without a phone signal.

Point of Contact: Amanda Wooding Academic founder: Tamzin Lent

Visit the website

William Oak Diagnostics Life Sciences

William Oak Diagnostics

William Oak Diagnostics' vision is to eliminate micronutrient deficiencies. Their innovative point-of-care test with integrated blood-collection simplifies the identification of numerous micronutrient deficiencies.

Point of Contact: Amanda Wooding Academic founders: Alexander Patto, Tim Dwyer

Visit the website

Xterna Life Sciences

Xterna

Xterna offers novel solutions for cell-type specific drug delivery, leveraging advanced biotechnology to improve therapeutic outcomes.

Point of Contact: Amanda Wooding Academic founders: Chris Wan, Jessica Corry

Visit the website